June 2020
Volume 61, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2020
Intraocular biomarkers in uveal melanoma: a proteomic study
Author Affiliations & Notes
  • Raffaele Parrozzani
    Department of Ophthalmology, University of Padova, Padova, Italy
  • Luisa Frizziero
    IRCCS – Fondazione Bietti, Rome, Italy
  • Silvia Bini
    Department of Ophthalmology, University of Padova, Padova, Italy
  • Eleonora Cosmo
    Department of Ophthalmology, University of Padova, Padova, Italy
  • Davide Londei
    Department of Ophthalmology, University of Padova, Padova, Italy
  • Giulia Marchione
    Department of Ophthalmology, University of Padova, Padova, Italy
  • Elisabetta Pilotto
    Department of Ophthalmology, University of Padova, Padova, Italy
  • Edoardo Midena
    Department of Ophthalmology, University of Padova, Padova, Italy
    IRCCS – Fondazione Bietti, Rome, Italy
  • Footnotes
    Commercial Relationships   Raffaele Parrozzani, None; Luisa Frizziero, None; Silvia Bini, None; Eleonora Cosmo, None; Davide Londei, None; Giulia Marchione, None; Elisabetta Pilotto, None; Edoardo Midena, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 2834. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Raffaele Parrozzani, Luisa Frizziero, Silvia Bini, Eleonora Cosmo, Davide Londei, Giulia Marchione, Elisabetta Pilotto, Edoardo Midena; Intraocular biomarkers in uveal melanoma: a proteomic study. Invest. Ophthalmol. Vis. Sci. 2020;61(7):2834.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Aim of the present study is to evaluate the presence of aqueous humour (AH) soluble biomarkers in eyes affected by uveal melanoma (UM) at the time of tumor treatment.

Methods : Thirty-five eyes affected by primary UM and thirty-five control eyes scheduled for cataract surgery underwent full ophthalmic examination and AH sample collection at time of surgical procedure (brachytherapy and cataract surgery, respectively). AH samples were analyzed by means of ELISA, to detect the concentration of selected cytokines, chemokines and growth factors. The specific concentrations of Interleukin-6 (IL-6), Interleukin-8 (IL-8), Regulated upon Activation, Normal T cell Expressed, and Secreted (RANTES), Epidermal Growth Factor (EGF), basic Fibroblast Growth Factor (bFGF), Monocyte Chemoattractant Protein-1 (MCP-1), Macrophage Inhibiting Factor (MIF) and Vascular Endothelial Growth Factor (VEGF) were calculated on the linearized standard curves

Results : Compared with the control group, higher levels of IL-6 (p=0.049), IL-8 (p=0.006), RANTES (p=0.008), EGF (p=0.032), bFGF (p=0.016), MIF (p=0.007) and MCP (p=0.020) were detected in eyes with UM. VEGF concentration difference between the two groups was borderline (p=0.058). Comparison study between clinical characteristics and cytokine concentrations showed a positive correlation between tumor thickness and IL-8 (p = 0.032) and degree of retinal detachment and IL-6 (p = 0.021).

Conclusions : UM is characterized by the presence of retinal neuroinflammatory, angiogenic and immune biomarkers in AH. The proteomic analysis of AH could characterize UM microenvironment, allowing to better understand its pathophysiology.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×